Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Walker

Showing results (201-210 of 568) with videos related to

Pageof 57
Sort By:
Statistics in Medicine|January 20, 2023
Practical approaches to Bayesian sample size determination in non-inferiority trials with binary outcomesRebecca M Turner, Michelle N Clements, Matteo Quartagno, et al.
Plos One|March 29, 2018
Overview of systematic reviews assessing the evidence for shorter versus longer duration antibiotic treatment for bacterial infections in secondary careIgho J Onakpoya, A Sarah Walker, Pui S Tan, et al.
The Journal of Infectious Diseases|April 11, 2014
Reduction of invasive pneumococcal disease 3 years after the introduction of the 13-valent conjugate vaccine in the Oxfordshire region of EnglandCatrin E Moore, John Paul, Dona Foster, et al.
The Pediatric Infectious Disease Journal|April 17, 2014
Pharmacokinetics of zidovudine dosed twice daily according to World Health Organization weight bands in Ugandan HIV-infected childrenQuirine Fillekes, Lindsay Kendall, Sabrina Kitaka, et al.
BMC Microbiology|March 14, 2014
Prevalence of Staphylococcus aureus protein A (spa) mutants in the community and hospitals in OxfordshireAntonina A Votintseva, Rowena Fung, Ruth R Miller, et al.
Antiviral Therapy|May 4, 2005
Plasma pharmacokinetics of once- versus twice-daily lamivudine and abacavir: simplification of combination treatment in HIV-1-infected children (PENTA-13)Alina Bergshoeff, David Burger, Corrien Verweij, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 28, 2013
Risk factors for Clostridium difficile acquisition in infants: importance of study designNicole E Stoesser, Jessica Martin, Damian Mawer, et al.
Plos One|July 10, 2020
Marginal structural models for repeated measures where intercept and slope are correlated: An application exploring the benefit of nutritional supplements on weight gain in HIV-infected children initiating antiretroviral therapyRuth E Farmer, Rhian Daniel, Deborah Ford, et al.
Plos One|November 23, 2013
Asymptomatic Clostridium difficile colonisation and onward transmissionDavid W Eyre, David Griffiths, Alison Vaughan, et al.
American Journal of Epidemiology|September 19, 2025
The cumulative incidence and infection hospitalization risk of SARS-CoV-2 by variant: a longitudinal study in EnglandCharlotte Gaughan, David Braunholtz, Leanne Massie, et al.
Pageof 57

Showing results (201-210 of 568) with videos related to

Sort By:
Pageof 57
Statistics in Medicine|January 20, 2023
Practical approaches to Bayesian sample size determination in non-inferiority trials with binary outcomesRebecca M Turner, Michelle N Clements, Matteo Quartagno, et al.
Plos One|March 29, 2018
Overview of systematic reviews assessing the evidence for shorter versus longer duration antibiotic treatment for bacterial infections in secondary careIgho J Onakpoya, A Sarah Walker, Pui S Tan, et al.
The Journal of Infectious Diseases|April 11, 2014
Reduction of invasive pneumococcal disease 3 years after the introduction of the 13-valent conjugate vaccine in the Oxfordshire region of EnglandCatrin E Moore, John Paul, Dona Foster, et al.
The Pediatric Infectious Disease Journal|April 17, 2014
Pharmacokinetics of zidovudine dosed twice daily according to World Health Organization weight bands in Ugandan HIV-infected childrenQuirine Fillekes, Lindsay Kendall, Sabrina Kitaka, et al.
BMC Microbiology|March 14, 2014
Prevalence of Staphylococcus aureus protein A (spa) mutants in the community and hospitals in OxfordshireAntonina A Votintseva, Rowena Fung, Ruth R Miller, et al.
Antiviral Therapy|May 4, 2005
Plasma pharmacokinetics of once- versus twice-daily lamivudine and abacavir: simplification of combination treatment in HIV-1-infected children (PENTA-13)Alina Bergshoeff, David Burger, Corrien Verweij, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 28, 2013
Risk factors for Clostridium difficile acquisition in infants: importance of study designNicole E Stoesser, Jessica Martin, Damian Mawer, et al.
Plos One|July 10, 2020
Marginal structural models for repeated measures where intercept and slope are correlated: An application exploring the benefit of nutritional supplements on weight gain in HIV-infected children initiating antiretroviral therapyRuth E Farmer, Rhian Daniel, Deborah Ford, et al.
Plos One|November 23, 2013
Asymptomatic Clostridium difficile colonisation and onward transmissionDavid W Eyre, David Griffiths, Alison Vaughan, et al.
American Journal of Epidemiology|September 19, 2025
The cumulative incidence and infection hospitalization risk of SARS-CoV-2 by variant: a longitudinal study in EnglandCharlotte Gaughan, David Braunholtz, Leanne Massie, et al.
Pageof 57